BioSpace News Archive

GenSight Biologics Reports Sustained Efficacy and Safety Among LHON Patients Three Years After LUMEVOQ® Treatment

GenSight Biologics, a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, reported that Leber Hereditary Optical Neuropathy subjects treated with LUMEVOQ® experienced sustained efficacy and safety three years after a single injection with the gene therapy.

July 6, 2020
·
8 min read
Business

University of Birmingham spinout company ChromaTwist named ‘one to watch’

University of Birmingham spinout company ChromaTwist has been named ‘one to watch’ in a competition recognising University-bred entrepreneurs bringing the hottest scientific discoveries into practical applications in medicine and technology.

July 6, 2020
·
4 min read
Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®

Masimo announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.

July 6, 2020
·
9 min read
Business

Medivir and SciLifeLab Enter Collaboration on Potential SARS CoV-2 Inhibitors

Medivir AB announced that it has entered a research collaboration with the Drug Discovery and Development Platform at SciLifeLab on potential inhibitors of SARS CoV-2.

July 6, 2020
·
3 min read
Business

Cytovance Biologics Announces Yuk Chun Chiu as Vice President of Manufacturing Operations

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization, announces Yuk Chun Chiu as Vice President of Manufacturing Operations.

July 6, 2020
·
2 min read
Policy

SINOMED® Completes Last Patient Follow-Up of the PIONEER-III Pivotal US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent.

July 6, 2020
·
2 min read
Deals

Mission Raises $15m and Expands its Relationship with Pfizer

Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes, announced that it has raised $15m in equity investment.

July 6, 2020
·
3 min read
Deals

Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2

July 6, 2020
·
6 min read
Business

Rentschler Biopharma and Vetter Team up With Joint Goal to Simplify Processes and Optimize Time-to-market

Vetter and Rentschler Biopharma, two globally operating Contract Development and Manufacturing Organizations, announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.

July 6, 2020
·
5 min read
Business

Invitation - Presentation of Sobi’s Q2 2020 Results

On 16 July, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the second quarter 2020.

July 6, 2020
·
1 min read